Hyperliquid Strategies (NASDAQ:PURR) Price Target Raised to $8.00

Key Points

• Cantor Fitzgerald raised its price target on Hyperliquid Strategies from $6.00 to $8.00 and kept an overweight rating, implying about 19% upside from the current price.
• Other analysts are mixed but generally constructive: Maxim Group initiated coverage with a buy and $10 target, while Chardan Capital also has a buy rating; the consensus view is Moderate Buy with an average target of $8.82.
• Hyperliquid Strategies shares opened at $6.71, with a market cap of about $831.84 million; the company recently reported a quarterly EPS loss of $7.43 on just $0.50 million in revenue.

Hyperliquid Strategies (NASDAQ:PURR - Get Free Report) had its price target lifted by equities researchers at Cantor Fitzgerald from $6.00 to $8.00 in a research note issued to investors on Monday, MarketBeat Ratings reports. The firm currently has an "overweight" rating on the stock. Cantor Fitzgerald's price target points to a potential upside of 19.23% from the company's current price.

Other research analysts have also recently issued reports about the stock. Maxim Group started coverage on shares of Hyperliquid Strategies in a research note on Friday, April 24th. They issued a "buy" rating and a $10.00 price objective on the stock. Chardan Capital upped their target price on Hyperliquid Strategies from $8.15 to $8.45 and gave the stock a "buy" rating in a research note on Thursday, February 12th. Weiss Ratings started coverage on Hyperliquid Strategies in a research note on Monday, March 2nd. They set a "sell (e)" rating for the company. Finally, Wall Street Zen upgraded Hyperliquid Strategies to a "hold" rating in a research note on Saturday, February 21st. Three equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $8.82.

Hyperliquid Strategies Stock Performance

Shares of PURR stock opened at $6.71 on Monday. The company has a market capitalization of $831.84 million, a PE ratio of -0.72 and a beta of 1.44. The company has a 50 day moving average of $5.53. Hyperliquid Strategies has a 1 year low of $3.01 and a 1 year high of $7.09.

Hyperliquid Strategies (NASDAQ:PURR - Get Free Report) last issued its quarterly earnings results on Wednesday, February 11th. The company reported ($7.43) earnings per share (EPS) for the quarter. The company had revenue of $0.50 million during the quarter. On average, equities research analysts predict that Hyperliquid Strategies will post -1.15 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the stock. OMERS ADMINISTRATION Corp acquired a new position in shares of Hyperliquid Strategies during the fourth quarter worth $156,000. Galaxy Group Investments LLC acquired a new position in shares of Hyperliquid Strategies during the fourth quarter worth $15,167,000. Saba Capital Management L.P. acquired a new position in shares of Hyperliquid Strategies during the fourth quarter worth $2,494,000. Aristeia Capital L.L.C. acquired a new stake in Hyperliquid Strategies in the fourth quarter valued at $615,000. Finally, Jane Street Group LLC acquired a new stake in Hyperliquid Strategies in the fourth quarter valued at $339,000. 9.45% of the stock is currently owned by institutional investors and hedge funds.

Hyperliquid Strategies Company Profile

Hyperliquid Strategies Inc is a digital asset treasury company whose primary focus is to maximize shareholder value through accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. Hyperliquid Strategies Inc, formerly known as Sonnet BioTherapeutics Holdings Inc, is based in NEW YORK.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.